Indivior's US listing confirmation met with fall in shares
London-listed pharmaceuticals company Indivior PLC (LSE:INDV) has, as anticipated, confirmed that it will move its primary listing to the US. Shareholders...
Stay updated with breaking news from Mark Crossley. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
London-listed pharmaceuticals company Indivior PLC (LSE:INDV) has, as anticipated, confirmed that it will move its primary listing to the US. Shareholders...
SLOUGH, United Kingdom and RICHMOND, Va., Feb. 22, 2024 /PRNewswire/ -- Indivior PLC today announced its financial results for the period ending December 31, 2023. The earnings release, investor...
Shares in Indivior PLC rose on Thursday, after the company said that strong sales of its flagship Sublocade treatment had pushed its revenue to new heights, and it added that it will begin talks with...
Move is latest in number of delistings and IPO snubs to London Stock Exchange, including Tui
Indivior, the opioid dependence treatment maker has today said it will start consultations with on plans to shift its primary listing.